Search Results - "GILL, John F"

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial by SMALL, William, BERLIN, Jordan, KINSELLA, Timothy J, MERCHANT, Nipun B, HOFFMAN, John P, BENSON, Al B, NICOL, Steven, XU, Rong M, GILL, John F, MCGINN, Cornelius J, FREEDMAN, Gary M, LAWRENCE, Theodore, TALAMONTI, Mark S, MULCAHY, Mary F, BAPSI CHAKRAVARTHY, A, KONSKI, Andre A, ZALUPSKI, Mark M, PHILIP, Philip A

“…Gemcitabine is effective in the treatment of pancreatic cancer and is a potent radiosensitizer. This study assessed safety and efficacy of full-dose…”
Get full text

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study by Richards, Donald A., Kuefler, Paul R., Becerra, Carlos, Wilfong, Lalan S., Gersh, Robert H., Boehm, Kristi A., Zhan, Feng, Asmar, Lina, Myrand, Scott P., Hozak, Rebecca R., Zhao, Luping, Gill, John F., Mullaney, Brian P., Obasaju, Coleman K., Nicol, Steven J.

“…Summary Purpose Gemcitabine (G) is standard therapy for pancreatic cancer. Enzastaurin (E) inhibits PKCβ and PI3K/AKT signaling pathways with a dose-dependent…”
Get full text

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer by Madajewicz, Stefan, Waterhouse, David M., Ritch, Paul S., Khan, M. Qaseem, Higby, Donald J., Leichman, Cynthia G., Malik, Sandeep K., Hentschel, Patricia, Gill, John F., Zhao, Luping, Nicol, Steven J.

“…Summary Purpose To assess safety and efficacy of folinic acid, 5-fluorouracil, gemcitabine (FFG) and folinic acid, fluorouracil, oxaliplatin (FOLFOX4) regimens…”
Get full text

Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer by Gordon, Alan N, Teneriello, Michael, Janicek, Mike F, Hines, Jeffrey, Lim, Peter C, Chen, M. Dwight, Vaccarello, Luis, Homesley, Howard D, McMeekin, Scott, Burkholder, Tiana L, Wang, Yanping, Zhao, Luping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F

“…Abstract Objective The safety and efficacy of gemcitabine plus carboplatin (GC) or paclitaxel plus carboplatin (TC) induction regimens with or without…”
Get full text

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study by Richards, Donald A., Kuefler, Paul R., Becerra, Carlos, Wilfong, Lalan S., Gersh, Robert H., Boehm, Kristi A., Zhan, Feng, Asmar, Lina, Myrand, Scott P., Hozak, Rebecca R., Zhao, Luping, Gill, John F., Mullaney, Brian P., Obasaju, Coleman K., Nicol, Steven J.

Get full text

3-Hydroxy-3-methylglutaryl-CoA reductase by Rodwell, V W, Beach, M J, Bischoff, K M, Bochar, D A, Darnay, B G, Friesen, J A, Gill, J F, Hedl, M, Jordan-Starck, T, Kennelly, P J, Kim, D Y, Wang, Y

Get more information

Transfer of a β-turn structure to a new protein context by Hynes, Thomas R, Kautz, Roger A, Goodman, Margaret A, Gill, John F, Fox, Robert O

“…Four-residue beta-turns and larger loop structures represent a significant fraction of globular protein surfaces and play an important role in determining the…”
Get full text

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy by Gordon, Alan N, Teneriello, Michael, Lim, Peter, Janicek, Mike F, Burkholder, Tiana L, Wang, Yanping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F

“…Abstract Background Combination paclitaxel and carboplatin (TC) is the standard of care for first-line (induction) treatment of ovarian cancer. Gemcitabine…”
Get full text

Phase III Trial of Induction Gemcitabine or Paclitaxel Plus Carboplatin Followed by Elective Paclitaxel Consolidation in Ovarian Cancer: Interim Analysis of Induction Chemotherapy by Gordon, Alan N, Teneriello, Michael, Lim, Peter, Janicek, Mike F, Burkholder, Tiana L, Wang, Yanping, Orlando, Mauro, Obasaju, Coleman K, Gill, John F, Tai, Datchen F

“…Abstract Background Combination paclitaxel and carboplatin (TC) is the standard of care for first-line (induction) treatment of ovarian cancer. Gemcitabine…”
Get full text

Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene by DERETIC, V, GILL, J. F, CHAKRABARTY, A. M

“…Pulmonary infection by mucoid, alginate producing, Pseudomonas aeruginosa is a major complication in patients suffering from cystic fibrosis (CF). To analyze…”
Get full text

Transfer of a (Beta)-Turn Structure to a New Protein Context by Hynes, Thomas R, Kautz, Roger A, Goodman, Margaret A, Gill, John F, Fox, Robert O

“…Four-residue beta-turns and larger loop structures represent a significant fraction of globular protein surfaces and play an important role in determining the…”
Get full text